Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-07-01
1997-07-01
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5462724, 5462744, 514337, 514340, 514345, 514346, 514350, 514351, 514318, 514326, A61K 31535, A61K 31505, A61K 31445, A61K 31411
Patent
active
056439067
ABSTRACT:
A class of N-arylheteroarylalkyl imidazol-2-one compounds is described for use in treatment of a glaucoma disorder. Compounds of particular interest are angiotensin II antagonists of the formula ##STR1## wherein A is selected from ##STR2## wherein R.sup.1 is selected from hydrido and alkyl; wherein each of R.sup.2, R.sup.3 and R.sup.4 is independently selected from hydrido, alkyl, alkoxy, halo, hydroxy, carboxyl, alkoxycarbonyl, formyl and acetyl; wherein R.sup.5 is hydrido; wherein R.sup.6 is alkyl; wherein R.sup.7 is an acidic group selected from COOH and ##STR3## or a stereoisomer or a tautomer thereof or a pharmaceutically-acceptable salt thereof.
Manning Robert E.
Reitz David B.
Covington Raymond
G.D. Searle & Co.
Ivy C. Warren
Keane J. Timothy
LandOfFree
Method of using N-arylheteroarylalkyl imidazol-2-one compounds f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using N-arylheteroarylalkyl imidazol-2-one compounds f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using N-arylheteroarylalkyl imidazol-2-one compounds f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597306